C07D 211/90, C07C 233/88
Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
Weeber, Edwin John; Li, Qingyou; Peters, Melinda Marie; and Soueidan, Hana Marie, "Drug-induced activation of the Reelin signaling system" (2022). USF Patents. 1291.
University of South Florida